REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sgbiomed Cia.Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sgbiomed Cia.Ltda Profile Updated: April 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Sgbiomed Cia.Ltda is a company based in Ecuador, with its head office in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on September 11, 2014. Sgbiomed Cia.Ltda currently employs 7 (2021) people. From the latest financial highlights, Sgbiomed Cia.Ltda reported a net sales revenue drop of 3.93% in 2023. A negative growth of 33.79% was recorded in its total assets. The net profit margin of Sgbiomed Cia.Ltda decreased by 0.16% in 2023.

Headquarters
Mucho Lote 27
Guayaquil; Guayas;

Contact Details: Purchase the Sgbiomed Cia.Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Sgbiomed Cia.Ltda report to view the information.
Outstanding Shares:
Purchase the Sgbiomed Cia.Ltda report to view the information.
Registered Capital:
Purchase the Sgbiomed Cia.Ltda report to view the information.
Incorporation Date:
September 11, 2014
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
33.5%
Purchase this report to view the information.
33.25%
Purchase this report to view the information.
33.25%
Company Performance
Financial values in the chart are available after Sgbiomed Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-3.93%▼
Total operating revenue
-3.93%▼
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-96.34%▼
Total assets
-33.79%▼
Total equity
-27.24%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-0.16%▼
Return on Equity (ROE)
-0.19%▼
Debt to Equity Ratio
-9.26%▼
Quick Ratio
-0.03%▼
Cash Ratio
1.13%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo